Warfarin Sodium

A Study to Determine the Effects of Multiple Doses of Mipomersen (200 mg SC) on the Pharmacodynamics and Pharmacokinetics of Single-dose Warfarin

Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy Volunteers

Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers

Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan in Healthy Male Volunteers

A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation

Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose

Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus

Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi

Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non valvular atrial fibrillation: a randomized controlled trial

Anticoagulant Therapy in patients with atrial fibrillation after surgical Left Atrial Appendage Closure: a randomized non-inferiority trial (the ATLAAC trial)

NOTION-4: Prospective study on the impact of different anti-thrombotic therapies on subclinical leaflet thickening and its temporal dynamics in transcatheter bioprosthetic aortic valves.

Rivaroxaban in Idiopathic Membranous Nephropathy

D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy

Clinical Outcomes Among Non-valvular Atrial Fibrillation Patients With Renal Dysfunction

Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy

Gene-guided Warfarin for Anticoagulation Therapy

A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis